Chapter
1. Introduction
|
1.1. Market Definition
|
1.2. Research Scope
|
1.2.1. Markets Covered
|
1.2.2. Years Considered for
Study
|
|
|
Chapter
2. Executive Summary
|
2.1. Summary Snapshot Market Size
and Forecast, 2020-2030
|
2.2. Digital Therapeutics Market Share
by Application, 2022 vs 2030 (USD Million)
|
2.3. Digital Therapeutics Market Share
by Sales Channel, 2022 vs 2030 (USD Million)
|
2.4. Digital Therapeutics Market Share
by Region, 2022 vs 2030 (USD Million)
|
|
|
Chapter
3. Key Insights
|
|
|
Chapter
4. Digital Therapeutics Market Segmentation & Impact Analysis
|
4.1. Digital Therapeutics Market
Indicators Analysis
|
4.1.1. Market Drivers
Analysis
|
4.1.1.1. Increasing
incidence of preventable chronic diseases
|
4.1.1.2. Rising
focus on preventive healthcare
|
4.1.1.3. Need to
control healthcare costs
|
4.1.2. Market Restraint
Analysis
|
4.1.2.1. Patient
data privacy concerns
|
4.1.3. Market Opportunity
Analysis
|
4.1.3.1. Emerging
markets
|
4.2. Regulatory Analysis
|
4.2.1. North America
|
4.2.1.1. U.S.
|
4.2.1.2. Canada
|
4.2.2. Europe
|
4.2.2. Asia Pacific
|
4.2.2.1. India
|
4.2.2.2. Japan
|
4.2.2.3. China
|
4.3. Technological Insights
|
4.4. COVID-19 Impact analysis on Digital
Therapeutics Market
|
4.5. Porter’s Five Forces Analysis
|
4.5.1. Bargaining Power of
Buyers/Consumers
|
4.5.2. Bargaining Power of
Suppliers
|
4.5.3. Threat of New Entrants
|
4.5.4. Threat of Substitute
Products
|
4.5.4. Intensity of Competitive
Rivalry
|
4.6. Competitive Metric Space Analysis
|
|
|
Chapter
5. Digital Therapeutics Market, By Application (Market Size and Forecast
by Value - USD Million, 2020 - 2030)
|
5.1. Digital Therapeutics Market, By
Application (Market Size and Forecast by Value - USD Million, 2022 &
2030)
|
5.1.1. Preventive Applications
|
5.1.1.1. Preventive Applications Market Estimates
and Forecast, 2020-2030 (USD Million)
|
5.1.1.2. Preventive Applications Market Estimates
and Forecast, By Region, 2020-2030 (USD Million)
|
5.1.1.3. Prediabetes
|
5.1.1.3.1. Prediabetes Market Estimates and Forecast, 2020-2030 (USD
Million)
|
5.1.1.3.2. Prediabetes Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.1.4. Obesity
|
5.1.1.4.1. Obesity Market Estimates and Forecast, 2020-2030 (USD
Million)
|
5.1.1.4.2. Obesity Market Estimates and Forecast, By Region, 2020-2030
(USD Million)
|
5.1.1.5. Nutrition
|
5.1.1.5.1. Nutrition Market Estimates and Forecast, 2020-2030 (USD
Million)
|
5.1.1.5.2. Nutrition Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.1.6. Lifestyle Management
|
5.1.1.6.1. Lifestyle Management Market Estimates and Forecast,
2020-2030 (USD Million)
|
5.1.1.6.2. Lifestyle Management Market Estimates and Forecast, By
Region, 2020-2030 (USD Million)
|
5.1.1.7. Other Preventive Applications
|
5.1.1.7.1. Other Preventive Applications Market Estimates and
Forecast, 2020-2030 (USD Million)
|
5.1.1.7.2. Other Preventive Applications Market Estimates and
Forecast, By Region, 2020-2030 (USD Million)
|
5.1.2. Treatment/Care-related
Applications
|
5.1.2.1.
Treatment/Care-related Applications Market Estimates and Forecast, 2020-2030
(USD Million)
|
5.1.2.2.
Treatment/Care-related Applications Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.2.3. Diabetes
|
5.1.2.3.1. Diabetes Market Estimates and Forecast, 2020-2030 (USD
Million)
|
5.1.2.3.2. Diabetes Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.2.4. CNS Disorders
|
5.1.2.4.1. CNS Disorders Market Estimates and Forecast, 2020-2030 (USD
Million)
|
5.1.2.4.2. CNS Disorders Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.2.5. Chronic Respiratory Disorders
|
5.1.2.5.1. Chronic Respiratory Disorders Market Estimates and
Forecast, 2020-2030 (USD Million)
|
5.1.2.5.2. Chronic Respiratory Disorders Market Estimates and
Forecast, By Region, 2020-2030 (USD Million)
|
5.1.2.6. Musculoskeletal Disorders
|
5.1.2.6.1. Musculoskeletal Disorders Market Estimates and Forecast,
2020-2030 (USD Million)
|
5.1.2.6.2. Musculoskeletal Disorders Market Estimates and Forecast, By
Region, 2020-2030 (USD Million)
|
5.1.2.7. Cardiovascular Diseases
|
5.1.2.7.1. Cardiovascular Diseases Market Estimates and Forecast,
2020-2030 (USD Million)
|
5.1.2.7.2. Cardiovascular Diseases Market Estimates and Forecast, By
Region, 2020-2030 (USD Million)
|
5.1.2.8. Smoking Cessation
|
5.1.2.8.1. Smoking Cessation Market Estimates and Forecast, 2020-2030
(USD Million)
|
5.1.2.8.2. Smoking Cessation Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.2.9. Medication Adherence
|
5.1.2.9.1. Medication Adherence Market Estimates and Forecast,
2020-2030 (USD Million)
|
5.1.2.9.2. Medication Adherence Market Estimates and Forecast, By
Region, 2020-2030 (USD Million)
|
5.1.2.10. Gastrointestinal Disorders
|
5.1.2.10.1. Gastrointestinal Disorders Market Estimates and Forecast,
2020-2018 (USD Million)
|
5.1.2.10.2. Gastrointestinal Disorders Market Estimates and Forecast,
By Region, 2020-2018 (USD Million)
|
5.1.2.11. Substance Use & Addiction Management
|
5.1.2.11.1. Substance Use & Addiction
Management Market Estimates and Forecast, 2020-2030 (USD Million)
|
5.1.2.11.2. Substance Use & Addiction Management Market Estimates
and Forecast, By Region, 2020-2030 (USD Million)
|
5.1.2.12. Rehabilitation & Patient Care
|
5.1.2.12.1. Rehabilitation & Patient Care Market Estimates and
Forecast, 2020-2030 (USD Million)
|
5.1.2.12.2.
Rehabilitation & Patient Care Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
5.1.2.13. Other Treatment/Care-related Applications
|
5.1.2.13.1. Other Treatment/Care-related Applications Market Estimates
and Forecast, 2020-2018 (USD Million)
|
5.1.2.13.2. Other Treatment/Care-related Applications Market Estimates
and Forecast, By Region, 2020-2018 (USD Million)
|
|
|
Chapter
6. Digital Therapeutics Market, By Sales Channel (Market Size and
Forecast by Value - USD Million, 2020 - 2030)
|
6.1. Digital Therapeutics Market, By
Sales Channel (Market Size and Forecast by Value - USD Million, 2022 &
2030)
|
6.1.1. B2C
|
6.1.1.1. B2C Market Estimates and Forecast,
2020-2030 (USD Million)
|
6.1.1.2. B2C Market Estimates and Forecast, By
Region, 2020-2030 (USD Million)
|
6.1.2. Patients
|
6.1.2.1. Patients Market Estimates and Forecast,
2020-2030 (USD Million)
|
6.1.2.2. Patients Market Estimates and Forecast, By
Region, 2020-2030 (USD Million)
|
6.1.3. Caregivers
|
6.1.3.1. Caregivers
Market Estimates and Forecast, 2020-2030 (USD Million)
|
6.1.3.2. Caregivers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
6.1.4. B2B
|
6.1.4.1. B2B Market
Estimates and Forecast, 2020-2030 (USD Million)
|
6.1.4.2. B2B Market
Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
6.1.5. Providers
|
6.1.5.1. Providers
Market Estimates and Forecast, 2020-2030 (USD Million)
|
6.1.5.2. Providers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
6.1.6. Payers
|
6.1.6.1. Payers Market Estimates and
Forecast, 2020-2030 (USD Million)
|
6.1.6.2. Payers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
6.1.7. Employers
|
6.1.7.1. Employers
Market Estimates and Forecast, 2020-2030 (USD Million)
|
6.1.7.2. Employers
Market Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
6.1.8. Pharmaceutical Companies
|
6.1.8.1.
Pharmaceutical Companies Market Estimates and Forecast, 2020-2030 (USD
Million)
|
6.1.8.2.
Pharmaceutical Companies Market Estimates and Forecast, By Region, 2020-2030
(USD Million)
|
6.1.9. Other Buyers
|
6.1.9.1. Other
Buyers Market Estimates and Forecast, 2020-2030 (USD Million)
|
6.1.9.2. Other
Buyers Market Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
|
|
Chapter
7. Digital Therapeutics Market, By Region (Market Size and Forecast by Value
- USD Million, 2020 - 2030)
|
7.1. Digital Therapeutics Market, By
Region (Market Size and Forecast by Value - USD Million, 2022 & 2030)
|
7.2. North America
|
7.2.1. North America Digital
Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.2.2. North America Digital Therapeutics
Market, By Sales Channel, 2020-2030 (USD Million)
|
7.2.3. North America Digital
Therapeutics Market, By Country, 2020-2030 (USD Million)
|
7.2.4. U.S.
|
7.2.4.1. U.S.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.2.4.2. U.S.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.2.5. Canada
|
7.2.5.1. Canada
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.2.5.2. Canada
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3. Europe
|
7.3.1. Europe Digital
Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.2. Europe Digital
Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3.3. Europe Digital Therapeutics
Market, By Country, 2020-2030 (USD Million)
|
7.3.4. Germany
|
7.3.4.1. Germany
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.4.2. Germany
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3.5. U.K.
|
7.3.5.1. U.K.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.5.2. U.K.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3.6. France
|
7.3.6.1. France
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.6.2. France
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3.7. Spain
|
7.3.7.1. Spain
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.7.2. Spain
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3.8. Italy
|
7.3.8.1. Italy
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.8.2. Italy
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.3.9. Rest of Europe
|
7.3.9.1. Rest of
Europe Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.3.9.2. Rest of
Europe Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
|
|
7.4. Asia Pacific
|
7.4.1. Asia Pacific Digital
Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.4.2. Asia Pacific Digital
Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.4.3. Asia Pacific Digital
Therapeutics Market, By Country, 2020-2030 (USD Million)
|
7.4.4. India
|
7.4.4.1. India
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.4.4.2. India
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.4.4.3. India
Digital Therapeutics Market, By , 2020-2030 (USD Million)
|
7.4.5. Japan
|
7.4.5.1. Japan Digital
Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.4.5.2. Japan
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.4.5.3. Japan
Digital Therapeutics Market, By , 2020-2030 (USD Million)
|
7.4.6. China
|
7.4.6.1. China
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.4.6.2. China
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.4.6.3. China
Digital Therapeutics Market, By , 2020-2030 (USD Million)
|
7.4.7. South Korea
|
7.4.7.1. South
Korea Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.4.7.2. South
Korea Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.4.7.3. South Korea Digital
Therapeutics Market, By , 2020-2030 (USD Million)
|
7.4.8. Australia
|
7.4.8.1.
Australia Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
7.4.8.2.
Australia Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
7.4.8.3.
Australia Digital Therapeutics Market, By , 2020-2030 (USD Million)
|
7.4.9. Rest of Asia Pacific
|
7.4.9.1. Rest of
Asia Pacific Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
7.4.9.2. Rest of
Asia Pacific Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
7.4.9.3. Rest of
Asia Pacific Digital Therapeutics Market, By , 2020-2030 (USD Million)
|
|
|
7.5. Middle East & Africa
|
7.5.1. Middle East & Africa
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.5.2. Middle East &
AfricaDigital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.5.3. Middle East & Africa
Digital Therapeutics Market, By Country, 2020-2030 (USD Million)
|
7.5.4. UAE
|
7.4.5.1. UAE
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.4.5.2. UAE
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.5.5. Saudi Arabia
|
7.5.5.1. Saudi
Arabia Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.5.5.2. Saudi
Arabia Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.5.6. South Africa
|
7.5.6.1. South
Africa Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.5.6.2. South
Africa Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.5.7. Rest of Middle East
& Africa
|
7.5.7.1. Rest of
Middle East & Africa Digital Therapeutics Market, By Application,
2020-2030 (USD Million)
|
7.5.7.2. Rest of
Middle East & Africa Digital Therapeutics Market, By Sales Channel,
2020-2030 (USD Million)
|
|
|
7.6. Latin America
|
7.6.1. Latin America Digital
Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.6.2. Latin America Digital
Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.6.3. Latin America Digital Therapeutics
Market, By Country, 2020-2030 (USD Million)
|
7.6.4. Brazil
|
7.6.4.1. Brazil
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.6.4.2. Brazil
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.6.5. Mexico
|
7.6.5.1. Mexico
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
7.6.5.2. Mexico
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
7.6.6. Argentina
|
7.6.6.1.
Argentina Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
7.6.6.2.
Argentina Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
7.6.7. Rest of Latin America
|
7.6.7.1. Rest of
Latin America Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
7.6.7.2. Rest of
Latin America Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
|
|
Chapter
8. Competitive Landscape
|
8.1. Market Revenue Share by
Manufacturers
|
8.2. Competitor’s Positioning
|
8.3. Strategy Benchmarking
|
8.3.1. Partnership &
Agreement
|
8.3.2. New Product Development
|
8.3.3. Mergers &
Acquisitions
|
8.3.4. Investment &
Expansion
|
8.4. Vendor Landscape
|
8.4.1. Distributors
|
8.4.2. North America
|
8.4.3. Europe
|
8.4.4. Asia Pacific
|
8.4.5. Middle East &
Africa
|
8.4.6. Latin America
|
8.5. Zettabyte Analytics Insights for
Competitive Landscape
|
|
|
Chapter
9. Company Profiles
|
9.1. 2Morrow
|
9.1.1. Company Overview
|
9.1.2. Products Offered
|
9.1.3. Financials
|
9.1.4. Recent Development
|
9.2. Akili
|
9.2.1. Company Overview
|
9.2.2. Products Offered
|
9.2.3. Financials
|
9.2.4. Recent Development
|
9.3. Ayogo
|
9.3.1. Company Overview
|
9.3.2. Products Offered
|
9.3.3. Financials
|
9.3.4. Recent Development
|
9.4. Behavr
|
9.4.1. Company Overview
|
9.4.2. Products Offered
|
9.4.3. Financials
|
9.4.4. Recent Development
|
9.5. Better Therapeutics
|
9.5.1. Company Overview
|
9.5.2. Products Offered
|
9.5.3. Financials
|
9.5.4. Recent Development
|
9.6. Canary Health
|
9.6.1. Company Overview
|
9.6.2. Products Offered
|
9.6.3. Financials
|
9.6.4. Recent Development
|
9.7. Click Therapeutics
|
9.7.1. Company Overview
|
9.7.2. Products Offered
|
9.7.3. Financials
|
9.7.4. Recent Development
|
9.8. Cognifit
|
9.8.1. Company Overview
|
9.8.2. Products Offered
|
9.8.3. Financials
|
9.8.4. Recent Development
|
9.9. Cognoa
|
9.9.1. Company Overview
|
9.9.2. Products Offered
|
9.9.3. Financials
|
9.9.4. Recent Development
|
9.10. Freespira
|
9.10.1. Company Overview
|
9.10.2. Products Offered
|
9.10.3. Financials
|
9.10.4. Recent
Development
|
9.11. Ginger
|
9.11.1. Company Overview
|
9.11.2. Products Offered
|
9.11.3. Financials
|
9.11.4. Recent
Development
|
9.12. Hinge Health
|
9.12.1. Company Overview
|
9.12.2. Products Offered
|
9.12.3. Financials
|
9.12.4. Recent
Development
|
9.13. Kaia Health
|
9.13.1. Company Overview
|
9.13.2. Products Offered
|
9.13.3. Financials
|
9.13.4. Recent
Development
|
9.14. Mindable Health
|
9.14.1. Company Overview
|
9.14.2. Products Offered
|
9.14.3. Financials
|
9.14.4. Recent
Development
|
9.15. Mindstrong Health
|
9.15.1. Company Overview
|
9.15.2. Products Offered
|
9.15.3. Financials
|
9.15.4. Recent
Development
|
9.16. Noom
|
9.16.1. Company Overview
|
9.16.2. Products Offered
|
9.16.3. Financials
|
9.16.4. Recent
Development
|
9.17. Omada Health
|
9.17.1. Company Overview
|
9.17.2. Products Offered
|
9.17.3. Financials
|
9.17.4. Recent
Development
|
9.18. Orexo Ab
|
9.18.1. Company Overview
|
9.18.2. Products Offered
|
9.18.3. Financials
|
9.18.4. Recent
Development
|
9.19. Pear Therapeutics
|
9.19.1. Company Overview
|
9.19.2. Products Offered
|
9.19.3. Financials
|
9.19.4. Recent
Development
|
9.20. Propeller Health
|
9.20.1. Company Overview
|
9.20.2. Products Offered
|
9.20.3. Financials
|
9.20.4. Recent
Development
|
9.21. Teladoc Health
|
9.21.1. Company Overview
|
9.21.2. Products Offered
|
9.21.3. Financials
|
9.21.4. Recent
Development
|
9.22. Twill
|
9.22.1. Company Overview
|
9.22.2. Products Offered
|
9.22.3. Financials
|
9.22.4. Recent
Development
|
9.23. Virta Health Corp
|
9.23.1. Company Overview
|
9.23.2. Products Offered
|
9.23.3. Financials
|
9.23.4. Recent
Development
|
9.24. Welldoc
|
9.24.1. Company Overview
|
9.24.2. Products Offered
|
9.24.3. Financials
|
9.24.4. Recent
Development
|
9.25. Wellthy Therapeutics
|
9.25.1. Company Overview
|
9.25.2. Products Offered
|
9.25.3. Financials
|
9.25.4. Recent
Development
|
|
|
Chapter
10. Research Methodology
|
10.1. Research Sources
|
10.1.1. Primary
|
10.1.2. Secondary
|
10.2. Market Size Estimation
|
|
|
Chapter
11. Appendix
|
11.1.
Discussion guide
|
11.2.
Knowledge Store: Zettabyte Analytics Subscription Portal
|
11.3.
Available Customizations
|
11.4.
Associated Zettabyte Analytics Reports
|
|
|
List of
Tables
|
Table 1
|
Digital
Therapeutics Market, By Application (Market Size and Forecast by Value - USD
Million, 2022 & 2030)
|
Table 2
|
Preventive
Applications Market Estimates and Forecast, 2020-2030 (USD Million)
|
Table 3
|
Preventive
Applications Market Estimates and Forecast, By Region, 2020-2030 (USD
Million)
|
Table 4
|
Treatment/Care-related
Applications Market Estimates and Forecast, 2020-2030 (USD Million)
|
Table 5
|
Treatment/Care-related
Applications Market Estimates and Forecast, By Region, 2020-2030 (USD
Million)
|
Table 6
|
Digital
Therapeutics Market, By Sales Channel (Market Size and Forecast by Value -
USD Million, 2022 & 2030)
|
Table 7
|
B2C
Market Estimates and Forecast, 2020-2030 (USD Million)
|
Table 8
|
B2C
Market Estimates and Forecast, By Region, 2020-2030 (USD Million)
|
Table 10
|
Market Estimates and Forecast, 2020-2030
(USD Million)
|
Table 11
|
Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
Table 12
|
Market Estimates and Forecast, 2020-2030
(USD Million)
|
Table 13
|
Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
Table 14
|
Market Estimates and Forecast, 2020-2030
(USD Million)
|
Table 15
|
Market Estimates and Forecast, By Region,
2020-2030 (USD Million)
|
Table 16
|
North
America Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 17
|
North
America Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
Table 19
|
North
America Digital Therapeutics Market, By Country, 2020-2030 (USD Million)
|
Table 20
|
U.S.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 21
|
U.S.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 23
|
Canada
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 24
|
Canada
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 26
|
Europe
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 27
|
Europe
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 29
|
Europe
Digital Therapeutics Market, By Country, 2020-2030 (USD Million)
|
Table 30
|
Germany
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 31
|
Germany
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 33
|
U.K.
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 34
|
U.K.
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 36
|
France
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 37
|
France
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 39
|
Spain
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 40
|
Spain
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 42
|
Italy
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 43
|
Italy
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 45
|
Rest of
Europe Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 46
|
Rest of
Europe Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 48
|
Asia
Pacific Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 49
|
Asia
Pacific Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
Table 51
|
Asia
Pacific Digital Therapeutics Market, By Country, 2020-2030 (USD Million)
|
Table 52
|
India
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 53
|
India
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 55
|
Japan
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 56
|
Japan
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 58
|
China
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 59
|
China
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 61
|
South
Korea Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 62
|
South
Korea Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 64
|
Australia
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 65
|
Australia
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 67
|
Rest of
Asia Pacific Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
Table 68
|
Rest of
Asia Pacific Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
Table 70
|
Middle
East & Africa Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
Table 71
|
Middle
East & Africa Digital Therapeutics Market, By Sales Channel, 2020-2030
(USD Million)
|
Table 73
|
Middle
East & Africa Digital Therapeutics Market, By Country, 2020-2030 (USD
Million)
|
Table 74
|
UAE
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 75
|
UAE
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 77
|
Saudi
Arabia Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 78
|
Saudi
Arabia Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 80
|
South
Africa Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 81
|
South
Africa Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 83
|
Rest of
Middle East & Africa Digital Therapeutics Market, By Application,
2020-2030 (USD Million)
|
Table 84
|
Rest of
Middle East & Africa Digital Therapeutics Market, By Sales Channel,
2020-2030 (USD Million)
|
Table 86
|
Latin
America Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 87
|
Latin America
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 89
|
Latin
America Digital Therapeutics Market, By Country, 2020-2030 (USD Million)
|
Table 90
|
Brazil
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 91
|
Brazil
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 93
|
Mexico
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 94
|
Mexico
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 96
|
Argentina
Digital Therapeutics Market, By Application, 2020-2030 (USD Million)
|
Table 97
|
Argentina
Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD Million)
|
Table 99
|
Rest of
Latin America Digital Therapeutics Market, By Application, 2020-2030 (USD
Million)
|
Table 100
|
Rest of
Latin America Digital Therapeutics Market, By Sales Channel, 2020-2030 (USD
Million)
|
Table 102
|
Product
Launch & Development in The Digital Therapeutics Market, 2020-2022
|
Table 103
|
Investment
and Expansion in The Digital Therapeutics Market, 2020-2022
|
Table 104
|
Partnership
& Collaboration in The Digital Therapeutics Market, 2020-2022
|
Table 105
|
Merger
& Acquisition in The Digital Therapeutics Market, 2020-2022
|
|
|
List of Figures
|
Figure 1
|
Research
Methodology
|
Figure 2
|
Summary
Snapshot Market Size and Forecast, USD Million, 2022 & 2030
|
Figure 3
|
Global
Digital Therapeutics Market Segmentation & Impact Analysis
|
Figure 4
|
Regulatory
Analysis
|
Figure 5
|
COVID-19
Impact analysis on Digital Therapeutics Market
|
Figure 6
|
Market
Revenue Share by Manufacturers
|
Figure 7
|
Digital
Therapeutics Market, By Application (Market Size and Forecast by Value - USD
Million, 2022 & 2030)
|
Figure 8
|
Digital
Therapeutics Market, By Sales Channel (Market Size and Forecast by Value -
USD Million, 2022 & 2030)
|
Figure 10
|
Digital
Therapeutics Market, By Region (Market Size and Forecast by Value - USD
Million, 2022 & 2030)
|